{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:20:57Z","timestamp":1790886057811,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Foundation of the National Key Laboratory of Respiratory Diseases","award":["SKLRD-Z-202308"],"award-info":[{"award-number":["SKLRD-Z-202308"]}]},{"name":"the Science and Technology Program of Guangzhou","award":["202201020434"],"award-info":[{"award-number":["202201020434"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-cystic fibrosis bronchiectasis is a chronic respiratory disease characterized by bronchial dilation. However, the significance of elevated eosinophil counts in acute exacerbations of bronchiectasis remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective case-control study included 169 hospitalized patients with acute exacerbations of non-cystic fibrosis bronchiectasis. Based on blood eosinophil levels, patients were categorized into eosinophilic and non-eosinophilic bronchiectasis groups. Various clinical variables, including lung function, comorbidities and clinical features were collected for analysis. The study aimed to examine the differences between these groups and their clinical phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eosinophilic bronchiectasis (EB) was present in approximately 22% of all hospitalized patients with bronchiectasis, and it was more prevalent among male smokers (\n                      <jats:italic>P\u2009&lt;\u2009<\/jats:italic>\n                      0.01). EB exhibited greater severity of bronchiectasis, including worse airway obstruction, higher scores in the E-FACED (FACED combined with exacerbations) and bronchiectasis severity index (BSI), a high glucocorticoids medication possession ratio, and increased hospitalization cost (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05 or\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). Furthermore, we observed a significant positive correlation between blood eosinophil count and both sputum eosinophils (r\u2009=\u20090.49,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) and serum total immunoglobulin E levels (r\u2009=\u20090.21,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Additional analysis revealed that patients with EB had a higher frequency of shortness of breath (\n                      <jats:italic>P\u2009&lt;\u2009<\/jats:italic>\n                      0.05), were more likely to have comorbid sinusitis (\n                      <jats:italic>P\u2009&lt;\u2009<\/jats:italic>\n                      0.01), and exhibited a greater number of lung segments affected by bronchiectasis (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that EB presents a distinct pattern of bronchiectasis features, confirming the notion that it is a specific phenotype.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00408-023-00668-w","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T17:01:55Z","timestamp":1705424515000},"page":"53-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Elevated Eosinophil Counts in Acute Exacerbations of Bronchiectasis: Unveiling a Distinct Clinical Phenotype"],"prefix":"10.1007","volume":"202","author":[{"given":"Weixin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nili","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naijian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"issue":"3","key":"668_CR1","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ et al (2017) European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J 50(3):1700629. https:\/\/doi.org\/10.1183\/13993003.00629-2017","journal-title":"Eur Respir J"},{"issue":"10150","key":"668_CR2","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","volume":"392","author":"PA Flume","year":"2018","unstructured":"Flume PA, Chalmers JD, Olivier KN (2018) Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet 392(10150):880\u2013890. https:\/\/doi.org\/10.1016\/S0140-6736(18)31767-7","journal-title":"Lancet"},{"issue":"8","key":"668_CR3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","volume":"9","author":"HR Keir","year":"2021","unstructured":"Keir HR, Shoemark A, Dicker AJ et al (2021) Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. Lancet Respir Med 9(8):873\u2013884. https:\/\/doi.org\/10.1016\/S2213-2600(20)30504-X","journal-title":"Lancet Respir Med"},{"issue":"2","key":"668_CR4","doi-asserted-by":"publisher","first-page":"2003157","DOI":"10.1183\/13993003.03157-2020","volume":"58","author":"YH Giam","year":"2021","unstructured":"Giam YH, Shoemark A, Chalmers JD (2021) Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism. Eur Respir J 58(2):2003157. https:\/\/doi.org\/10.1183\/13993003.03157-2020","journal-title":"Eur Respir J"},{"issue":"10154","key":"668_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(18)31723-9","volume":"392","author":"V Goyal","year":"2018","unstructured":"Goyal V, Grimwood K, Byrnes CA (2018) Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet 392(10154):1197\u20131206. https:\/\/doi.org\/10.1016\/S0140-6736(18)31723-9","journal-title":"Lancet"},{"issue":"8","key":"668_CR6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","volume":"205","author":"A Shoemark","year":"2022","unstructured":"Shoemark A, Shteinberg M, De Soyza A et al (2022) Characterization of eosinophilic bronchiectasis: a European Multicohort Study. Am J Respir Crit Care Med 205(8):894\u2013902. https:\/\/doi.org\/10.1164\/rccm.202108-1889OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"668_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jaip.2022.10.027","volume":"11","author":"WJ Guan","year":"2023","unstructured":"Guan WJ, Oscullo G, He MZ (2023) Significance and potential role of eosinophils in non-cystic fibrosis bronchiectasis. J Allergy Clin Immunol Pract 11(4):1089\u20131099. https:\/\/doi.org\/10.1016\/j.jaip.2022.10.027","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"668_CR8","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1164\/rccm.201709-1948OC","volume":"197","author":"S Svenningsen","year":"2018","unstructured":"Svenningsen S, Eddy RL, Lim HF et al (2018) Sputum eosinophilia and magnetic resonance imaging ventilation heterogeneity in severe asthma. Am J Respir Crit Care Med 197(7):876\u2013884. https:\/\/doi.org\/10.1164\/rccm.201709-1948OC","journal-title":"Am J Respir Crit Care Med"},{"key":"668_CR9","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2023 report). Available from: https:\/\/goldcopd.org\/2023-gold-report-2\/"},{"issue":"2","key":"668_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1183\/13993003.01312-2015","volume":"47","author":"HC Ellis","year":"2016","unstructured":"Ellis HC, Cowman S, Fernandes M et al (2016) Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study. Eur Respir J 47(2):482\u2013489. https:\/\/doi.org\/10.1183\/13993003.01312-2015","journal-title":"Eur Respir J"},{"issue":"5","key":"668_CR11","doi-asserted-by":"publisher","first-page":"1901874","DOI":"10.1183\/13993003.01874-2019","volume":"55","author":"S Hartl","year":"2020","unstructured":"Hartl S, Breyer MK, Burghuber OC et al (2020) Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J 55(5):1901874. https:\/\/doi.org\/10.1183\/13993003.01874-2019","journal-title":"Eur Respir J"},{"issue":"1","key":"668_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5588\/ijtld.22.0576","volume":"27","author":"MA Martinez-Garcia","year":"2023","unstructured":"Martinez-Garcia MA (2023) Eosinophils in bronchiectasis: searching for a new endotype. Int J Tuberc Lung Dis 27(1):5\u20136. https:\/\/doi.org\/10.5588\/ijtld.22.0576","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"668_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5588\/ijtld.22.0489","volume":"27","author":"WC Kwok","year":"2023","unstructured":"Kwok WC, Ho JCM, Ma TF et al (2023) Risk of hospitalised bronchiectasis exacerbation based on blood eosinophil counts. Int J Tuberc Lung Dis 27(1):61\u201365. https:\/\/doi.org\/10.5588\/ijtld.22.0489","journal-title":"Int J Tuberc Lung Dis"},{"key":"668_CR14","unstructured":"Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention, 2023. Updated May 2023. Available from: https:\/\/ginasthma.org\/"},{"issue":"9","key":"668_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","volume":"193","author":"S Vedel-Krogh","year":"2016","unstructured":"Vedel-Krogh S, Nielsen SF, Lange P et al (2016) Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. the copenhagen general population study. Am J Respir Crit Care Med 193(9):965\u2013974. https:\/\/doi.org\/10.1164\/rccm.201509-1869OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"668_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jaci.2014.04.005","volume":"134","author":"C Newby","year":"2014","unstructured":"Newby C, Agbetile J, Hargadon B et al (2014) Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe Asthma. J Allergy Clin Immunol 134(2):287\u2013294. https:\/\/doi.org\/10.1016\/j.jaci.2014.04.005","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"668_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.anl.2017.07.020","volume":"45","author":"K Uraguchi","year":"2018","unstructured":"Uraguchi K, Kariya S, Makihara S et al (2018) Pulmonary function in patients with eosinophilic chronic rhinosinusitis. Auris Nasus Larynx 45(3):476\u2013481. https:\/\/doi.org\/10.1016\/j.anl.2017.07.020","journal-title":"Auris Nasus Larynx"},{"issue":"6","key":"668_CR18","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jaip.2022.02.020","volume":"10","author":"M Abdo","year":"2022","unstructured":"Abdo M, Pedersen F, Kirsten AM, ALLIANCE study group (2022) Longitudinal impact of sputum inflammatory phenotypes on small airway dysfunction and disease outcomes in asthma. J Allergy Clin Immunol Pract 10(6):1545-1553e2. https:\/\/doi.org\/10.1016\/j.jaip.2022.02.020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"668_CR19","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3389\/fimmu.2018.02163","volume":"9","author":"Y Kuwabara","year":"2018","unstructured":"Kuwabara Y, Kobayashi T, D\u2019Alessandro-Gabazza CN et al (2018) Role of matrix metalloproteinase-2 in eosinophil-mediated airway remodeling. Front Immunol 9:2163. https:\/\/doi.org\/10.3389\/fimmu.2018.02163","journal-title":"Front Immunol"},{"key":"668_CR20","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/art.41727","volume":"73","author":"M Fukuchi","year":"2021","unstructured":"Fukuchi M, Kamide Y, Ueki S et al (2021) Eosinophil ETosis-mediated release of galectin-10 in eosinophilic granulomatosis with polyangiitis. Arthritis Rheumatol 73:1683\u20131693. https:\/\/doi.org\/10.1002\/art.41727","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"668_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12016-015-8525-4","volume":"50","author":"KA Ravin","year":"2016","unstructured":"Ravin KA, Loy M (2016) The eosinophil in infection. Clin Rev Allergy Immunol 50(2):214\u2013227. https:\/\/doi.org\/10.1007\/s12016-015-8525-4","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"668_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cmi.2020.04.007","volume":"27","author":"MA Martinez-Garc\u00eda","year":"2021","unstructured":"Martinez-Garc\u00eda MA, Oscullo G, Posadas T, Spanish Registry of Bronchiectasis Group of SEPAR (RIBRON) (2021) Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis. Clin Microbiol Infect 27(3):428\u2013434. https:\/\/doi.org\/10.1016\/j.cmi.2020.04.007","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"668_CR23","doi-asserted-by":"publisher","first-page":"1701953","DOI":"10.1183\/13993003.01953-2017","volume":"51","author":"D Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo D, Shteinberg M, Aliberti S et al (2018) The independent contribution of pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J 51(2):1701953","journal-title":"Eur Respir J"},{"issue":"15","key":"668_CR24","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.3390\/ijms23158127","volume":"23","author":"N Cer\u00f3n-Pisa","year":"2022","unstructured":"Cer\u00f3n-Pisa N, Shafiek H, Mart\u00edn-Medina A et al (2022) Effects of inhaled corticosteroids on the innate immunological response to pseudomonas aeruginosa infection in patients with COPD. Int J Mol Sci 23(15):8127. https:\/\/doi.org\/10.3390\/ijms23158127","journal-title":"Int J Mol Sci"},{"issue":"6","key":"668_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/thoraxjnl-2021-217160","volume":"77","author":"J Ekl\u00f6f","year":"2022","unstructured":"Ekl\u00f6f J, Ingebrigtsen TS, S\u00f8rensen R et al (2022) Use of inhaled corticosteroids and risk of acquiring pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease. Thorax 77(6):573\u2013580. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217160","journal-title":"Thorax"},{"issue":"9842","key":"668_CR26","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","volume":"380","author":"C Wong","year":"2012","unstructured":"Wong C, Jayaram L, Karalus N et al (2012) Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 380(9842):660\u2013667. https:\/\/doi.org\/10.1016\/S0140-6736(12)60953-2","journal-title":"Lancet"},{"issue":"3","key":"668_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","volume":"7","author":"CS Haworth","year":"2019","unstructured":"Haworth CS, Bilton D, Chalmers JD et al (2019) Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung Infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials. Lancet Respir Med 7(3):213\u2013226. https:\/\/doi.org\/10.1016\/S2213-2600(18)30427-2","journal-title":"Lancet Respir Med"},{"issue":"1","key":"668_CR28","doi-asserted-by":"publisher","first-page":"1901333","DOI":"10.1183\/13993003.01333-2019","volume":"55","author":"J Rademacher","year":"2020","unstructured":"Rademacher J, Konwert S, Fuge J et al (2020) Anti-IL5 and anti-IL5R\u03b1 therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series. Eur Respir J 55(1):1901333. https:\/\/doi.org\/10.1183\/13993003.01333-2019","journal-title":"Eur Respir J"},{"key":"668_CR29","doi-asserted-by":"publisher","first-page":"2300640","DOI":"10.1016\/j.jaip.2023.05.041","volume":"S2213\u20132198","author":"SA Bendien","year":"2023","unstructured":"Bendien SA, Kroes HA, van Hal LH et al (2023) Real-world effectiveness of interleukin-5\/5Ra targeted biologics in severe eosinophilic asthma with comorbid bronchiectasis. J Allergy Clin Immunol Pract S2213\u20132198:2300640\u20132300642. https:\/\/doi.org\/10.1016\/j.jaip.2023.05.041","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"668_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/biomedicines9070772","volume":"9","author":"M Oriano","year":"2021","unstructured":"Oriano M, Gramegna A, Amati F et al (2021) T2-High endotype and response to biological treatments in patients with bronchiectasis. Biomedicines 9(7):772. https:\/\/doi.org\/10.3390\/biomedicines9070772","journal-title":"Biomedicines"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-023-00668-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-023-00668-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-023-00668-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T10:07:53Z","timestamp":1708942073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-023-00668-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1007\/s00408-023-00668-w","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics committee approval was obtained from the First Affiliated Hospital of Guangzhou Medical University of the study (No.2022-55). Informed consent was waived because of the retrospective nature of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}